ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8,401 | 61.64798 | 0 | female | 0 | 8 | 1,328 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | $25-$50k | 0 | 5,194 | 3,546.2168 | 4,267.53906 | 6 | white | 29.398438 | 53 | 0.743896 | 0.596924 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 8 | 109 | 4.199219 | 110 | 24 | 36.09375 | 285.6875 | 3.399902 | 0.799927 | 3.299805 | 129 | 7.509766 | null | null | null | null | null | null | 2.67041 |
8,402 | 73.68695 | 0 | male | 0 | 4 | 1,323 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 4,337 | 2,941.3672 | 3,158.86914 | 15 | white | 17 | 12 | 0.85791 | 0.764893 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 4 | 99 | 19 | 107 | 20 | 36.29688 | 210 | 4.099609 | 0.5 | 1.199951 | 140 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 2.081543 |
8,403 | 70.51599 | 1 | female | 0 | 4 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 0 | 9,541 | 6,665.918 | 6,835.14844 | 33 | white | 35.398438 | 50 | 0.390991 | 0.271973 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 99 | 62.195313 | 64 | 32 | 35.79688 | 100 | null | 10.699219 | 0.899902 | 137 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.220703 |
8,404 | 81.77399 | 1 | male | 0 | 25 | 163 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | null | 0 | 82,252 | 58,002.0938 | 54,091.5625 | 24.75 | white | 26.898438 | 51 | 0.579956 | 0.469971 | 34 | 0 | 0 | no | null | null | no dnr | 25 | 58 | 21.398438 | 120 | 14 | 38.09375 | 257.125 | 2.599609 | 0.599976 | 2.399902 | 132 | 7.369141 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,405 | 64.05695 | 1 | male | 0 | 8 | 17 | Lung Cancer | Cancer | 1 | 10 | null | 0 | 8,466 | null | null | 17.5 | white | 35 | 25 | 0.228973 | 0.025997 | 1 | 0 | 0 | metastatic | 0.49 | 0.19 | dnr after sadm | 2 | 73 | 9.898438 | 110 | 24 | 35.69531 | 376 | 2.199707 | 0.5 | 0.899902 | 136 | 7.509766 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
8,406 | 85.22095 | 1 | female | 0 | 3 | 290 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 1,936 | 1,283.6807 | 1,240.06934 | 21 | white | 15.398438 | 16 | 0.773926 | 0.639893 | 1 | 0 | 0 | yes | 0.9 | 0.8 | dnr after sadm | 1 | 77 | 7.799805 | 73 | 20 | 35.79688 | 320 | 3.799805 | 0.599976 | 0.699951 | 135 | 7.429688 | null | null | null | null | null | null | 3.181152 |
8,407 | 68.75299 | 0 | female | 0 | 17 | 1,320 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 12,189 | 7,941.2812 | 7,425.61719 | 13 | white | 18.699219 | 21 | 0.861938 | 0.770996 | 1 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 17 | 82 | null | 81 | 26 | 36.09375 | 196.28125 | 3.399902 | 0.799927 | 1 | 136 | 7.339844 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
8,408 | 72.70599 | 0 | male | 0 | 21 | 1,319 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | $11-$25k | 26 | 81,726 | 53,869.1562 | 52,721.875 | 21 | white | 30.296875 | 42 | 0.422974 | 0.303955 | 24 | 0 | 0 | no | null | null | no dnr | 21 | 80 | 11.099609 | 112 | 27 | 36.89844 | 93.32812 | null | null | 1.399902 | 138 | 7.509766 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,409 | 67.146 | 1 | female | 1 | 57 | 57 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 184,437 | 121,788.375 | 132,234.75 | 35.5 | white | 20.398438 | 27 | 0.703979 | 0.61499 | 33 | 0 | 0 | no | 0.7 | 0.7 | dnr after sadm | 53 | 132 | 8.199219 | 150 | 8 | 39 | 315 | null | null | 0.599976 | 135 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.168945 |
8,410 | 67.30695 | 1 | female | 0 | 37 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 94,682 | 66,285.875 | 63,621.2812 | 28.75 | white | 29.796875 | 52 | 0.61792 | 0.512939 | 11 | 1 | 1 | no | null | null | dnr after sadm | 5 | 118 | 22.796875 | 120 | 26 | 36.59375 | 128.5625 | 2.799805 | 0.5 | 1.599854 | 141 | 7.25 | null | null | null | null | null | <2 mo. follow-up | 3.8125 |
8,411 | 79.90997 | 1 | male | 0 | 34 | 225 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 9 | 28,112 | 19,613.2969 | 19,509.2656 | 17.5 | white | 17.097656 | 26 | 0.829956 | 0.772949 | 1 | 0 | 1 | no | 0.7 | 0.7 | dnr after sadm | 2 | 68 | 20.699219 | 78 | 22 | 36.69531 | null | null | null | 1 | 133 | null | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
8,412 | 60.58899 | 0 | female | 0 | 47 | 1,316 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | under $11k | 0 | 109,058 | 75,702.5 | 67,278.625 | 31 | white | 38.398438 | 68 | 0.405945 | 0.28595 | 24 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 47 | 51 | 22 | 135 | 35 | 36.79688 | 192 | 2.599609 | 1.099854 | 4.899414 | 135 | 7.429688 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,413 | 69.80194 | 1 | male | 0 | 13 | 137 | COPD | COPD/CHF/Cirrhosis | 4 | 8 | under $11k | 0 | 10,474 | 7,049.2891 | 6,434.91797 | 11 | white | 23.898438 | 44 | 0.78894 | 0.661987 | 1 | 1 | 0 | no | 0.9 | 0.8 | dnr after sadm | 4 | 112 | null | 70 | 36 | 36 | 132 | null | null | 1.299805 | 137 | 7.299805 | null | null | null | null | null | no(M2 and SIP pres) | 3.908691 |
8,414 | 59.168 | 1 | male | 0 | 4 | 245 | Lung Cancer | Cancer | 1 | 19 | $25-$50k | 0 | 3,412 | 2,211.0644 | 2,123.4082 | 12 | white | 10.398438 | 16 | 0.826904 | 0.625 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 102 | 3.5 | 101 | 20 | 36.59375 | null | 4 | 0.5 | 1.199951 | 139 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.807861 |
8,415 | 69.09796 | 0 | male | 0 | 22 | 1,312 | Coma | Coma | 0 | 8 | null | 26 | 23,301 | 34,290.9688 | 33,719 | 20 | white | 18.699219 | 38 | 0.670898 | 0.613892 | 1 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 1 | 107 | 8.898438 | 78 | 36 | 37.69531 | 305 | 2.899902 | 0.5 | 2.399902 | 141 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,416 | 32.27399 | 1 | female | 0 | 37 | 124 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 80,302 | 49,708.4688 | 52,119.3125 | 26.75 | white | 28.5 | 38 | 0.790894 | 0.7229 | 25 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 5 | 107 | 5.899414 | 126 | 40 | 38.89844 | 152.5 | 2.399902 | 0.799927 | 0.599976 | 138 | 7.469727 | null | null | null | null | null | null | 2.404785 |
8,417 | 78.21198 | 1 | male | 0 | 7 | 38 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 3,987 | 2,706.4766 | 2,549.17969 | 6 | white | 18.796875 | 17 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 7 | 82 | 11.099609 | 104 | 24 | 36.59375 | null | 3.199707 | 1.199951 | 1.199951 | 136 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
8,418 | 59.87698 | 1 | male | 0 | 6 | 78 | Lung Cancer | Cancer | 3 | 12 | $11-$25k | 9 | 4,064 | 2,535.625 | 2,750.60938 | 7 | white | 26.296875 | 31 | 0.450989 | 0.138977 | 1 | 0 | 0 | metastatic | 0.39 | 0.19 | no dnr | 6 | 65 | 0.899902 | 63 | 20 | 36.39844 | null | 2.699707 | 0.5 | 0.599976 | 135 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.790039 |
8,419 | 75.93195 | 1 | male | 0 | 21 | 1,059 | CHF | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 29,476 | 19,041.3281 | 12,825.5625 | 18.666656 | white | 21.898438 | 42 | 0.80188 | 0.679932 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 21 | 63 | 5.099609 | 70 | 29 | 36.39844 | null | null | null | 2 | 131 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,420 | 68.05695 | 1 | male | 0 | 18 | 1,097 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 26 | 25,959 | 18,683.5469 | 18,205.5312 | 27.333328 | white | 28.398438 | 45 | 0.468994 | 0.349976 | 1 | 1 | 0 | yes | null | null | no dnr | 18 | 57 | 100 | 105 | 12 | 38.39844 | 131.65625 | 3.099609 | 1.699951 | 1.399902 | 146 | 7.489258 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
8,421 | 69.711 | 1 | male | 0 | 5 | 1,212 | Lung Cancer | Cancer | 2 | 8 | null | 0 | 5,852 | 3,574.4023 | 3,378.56836 | 7 | white | 25.5 | 25 | 0.487 | 0.167999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 108 | 5.799805 | 107 | 18 | 35.89844 | null | null | null | 1.299805 | 125 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,422 | 76.76898 | 1 | female | 1 | 12 | 12 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 7,139 | 4,815.7656 | 5,323.9375 | 15.5 | white | 25.097656 | 24 | 0.641968 | 0.332947 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 75 | 14.298828 | 110 | 22 | 35.59375 | null | 3.199707 | 0.5 | 0.899902 | 136 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
8,423 | 84.159 | 1 | female | 0 | 14 | 18 | Coma | Coma | 1 | 14 | null | 61 | 17,962 | 12,456.6641 | 12,592.9766 | 14 | white | 23.398438 | 41 | 0.172974 | 0.116989 | 4 | 0 | 0 | no | 0.25 | 0.1 | no dnr | 14 | 123 | 17.898438 | 150 | 36 | 38.19531 | null | null | null | 0.699951 | 136 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
8,424 | 66.30798 | 0 | male | 0 | 3 | 1,302 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 2,328 | 1,629.7373 | 1,673.83984 | 24 | white | 21.097656 | 25 | 0.845947 | 0.747925 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 121 | 6.099609 | 68 | 24 | 35.29688 | 342.8125 | 3.399902 | 0.799927 | 1.799805 | 140 | 7.379883 | null | null | null | null | null | no(M2 and SIP pres) | 2.312988 |
8,425 | 62.58197 | 0 | female | 0 | 9 | 1,305 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 8,455 | 6,367.9336 | 5,471.79688 | 11.5 | white | 23 | 21 | 0.827881 | 0.769897 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 91 | 12.398438 | 104 | 24 | 38.59375 | 140 | 3.099609 | 1.099854 | 0.899902 | 139 | 7.379883 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,426 | 66.13794 | 0 | female | 0 | 46 | 1,301 | Coma | Coma | 1 | 12 | under $11k | 41 | 132,609 | 94,985.75 | 91,633.4375 | 23.5 | white | 18.898438 | 30 | 0.515991 | 0.444946 | 27 | 0 | 0 | no | null | null | no dnr | 46 | 100 | null | 124 | 32 | 38 | null | null | null | null | 140 | null | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
8,427 | 63.90097 | 1 | male | 1 | 4 | 4 | Coma | Coma | 1 | null | null | 100 | 4,364 | 3,167.4707 | 3,277.06836 | 25 | null | 25.597656 | 43 | 0.174988 | 0.117996 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 3 | 123 | 10.599609 | 152 | 42 | 38.19531 | 155 | 3.099609 | 1 | 1.099854 | 142 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.584473 |
8,428 | 62.98199 | 1 | male | 0 | 3 | 479 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 3,867 | 2,166.8477 | 1,386.05957 | 7 | white | 17.398438 | 18 | 0.703979 | 0.419983 | 1 | 0 | 0 | metastatic | 0.95 | 0.5 | no dnr | 3 | 117 | 2.799805 | 104 | 20 | 36.09375 | null | null | 0.299988 | 1.199951 | 139 | null | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
8,429 | 68.11798 | 0 | female | 0 | 38 | 1,089 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 37 | 52,306 | 38,925.5625 | 31,323.5 | 21.5 | white | 24.898438 | 48 | 0.660889 | 0.562988 | 1 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 38 | 103 | 8.5 | 108 | 10 | 38.5 | null | null | null | null | 140 | null | null | null | 3,140 | null | 5 | adl>=4 (>=5 if sur) | 5 |
8,430 | 50.47198 | 1 | male | 0 | 7 | 647 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 5,953 | 3,888.6113 | 2,592.92969 | 7.5 | white | 19.5 | 9 | 0.901978 | 0.834961 | 1 | 0 | 0 | no | 0.85 | 0.65 | no dnr | 7 | 66 | 9.5 | 106 | 26 | 36 | 393.75 | 3.799805 | 1.5 | 1.899902 | 134 | 7.519531 | 155 | 32 | 350 | 0 | 2 | no(M2 and SIP pres) | 2 |
8,431 | 42.72699 | 0 | female | 0 | 13 | 1,088 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 62,248 | 40,416.125 | 42,746.7812 | 28.5 | white | 30 | 55 | 0.7229 | 0.637939 | 25 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 13 | 68 | 10.898438 | 67 | 11 | 38.5 | 204 | 2.099609 | 1 | 5.5 | 137 | 7.469727 | 120 | 55 | 100 | null | 0 | no(M2 and SIP pres) | 0 |
8,432 | 65.11694 | 1 | female | 0 | 7 | 172 | COPD | COPD/CHF/Cirrhosis | 2 | 7 | null | 0 | 6,253 | 4,228.2773 | 3,942.03906 | 4 | white | 9 | 17 | 0.92688 | 0.875977 | 1 | 0 | 0 | yes | 0.6 | 0.3 | dnr after sadm | 5 | 77 | 8.199219 | 97 | 22 | 36.79688 | null | 4.099609 | 1 | 0.899902 | 142 | null | 120 | 13 | 400 | 1 | null | no(M2 and SIP pres) | 1.166748 |
8,433 | 87.461 | 1 | female | 0 | 21 | 26 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 17,285 | 11,621.2344 | 9,995.19531 | 8.333328 | white | 13.599609 | 17 | 0.86499 | 0.775879 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 1 | 93 | 2.199707 | 60 | 20 | 36.19531 | null | 3.199707 | 2.099609 | 0.599976 | 138 | null | 103 | 13 | null | 0 | 3 | <2 mo. follow-up | 3 |
8,434 | 63.41998 | 1 | male | 0 | 12 | 72 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 9,577 | 6,214.8398 | 6,211.10938 | 8 | white | 28.699219 | 51 | 0.755981 | 0.613892 | 1 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 12 | 123 | 7.799805 | 79 | 32 | 35.09375 | 492 | 3.699707 | 1.099854 | 1.799805 | 135 | 7.439453 | 131 | 35 | 1,265 | null | null | null | 3.754395 |
8,435 | 69.24597 | 1 | female | 1 | 10 | 10 | MOSF w/Malig | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 17,546 | 11,843.5469 | 10,895.1953 | 18 | white | 23.398438 | 20 | 0.578979 | 0.468994 | 5 | 0 | 0 | metastatic | 0.5 | 0.4 | dnr after sadm | 9 | 126 | 27.5 | 109 | 26 | 35.89844 | 432 | 2.299805 | 1.199951 | 7.599609 | 131 | 7.339844 | 153 | 154 | 2,276 | null | 5 | <2 mo. follow-up | 5 |
8,436 | 63.83798 | 1 | female | 0 | 9 | 281 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 5,725 | 3,879.4102 | 2,918.94922 | 8 | white | 18 | 18 | 0.883911 | 0.805908 | 1 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 9 | 71 | 5.899414 | 76 | 16 | 36.69531 | null | 3.899902 | 0.899902 | 1.299805 | 134 | null | 86 | 16 | null | 0 | 1 | no(M2 and SIP pres) | 1 |
8,437 | 79.39795 | 0 | male | 0 | 10 | 1,082 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 8,833 | 6,296.0547 | 5,471.19922 | 10.5 | white | 24.5 | 28 | 0.708984 | 0.54895 | 1 | 0 | 0 | no | 0.99 | 0.8 | dnr before sadm | -1 | 109 | 5.5 | 132 | 8 | 39.5 | 399.625 | 1.699951 | 1.599854 | 0.799927 | 148 | 7.359375 | 152 | 21 | 1,225 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,438 | 75.56995 | 1 | female | 1 | 39 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 77,306 | 48,291.8438 | 50,790.875 | 23.75 | white | 23.597656 | 32 | 0.747925 | 0.668945 | 3 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 39 | 68 | 39.59375 | 68 | 24 | 36.09375 | null | 2.5 | 5.299805 | 2.399902 | 129 | null | 272 | 62 | 1,230 | null | 1 | <2 mo. follow-up | 1 |
8,439 | 34.65298 | 0 | male | 0 | 12 | 1,081 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 44 | 29,222 | 20,343.5312 | 19,508.7969 | 15 | white | 24.898438 | 48 | 0.731934 | 0.647949 | 8 | 0 | 0 | no | null | null | no dnr | 12 | 115 | 4.5 | 60 | 12 | 36.59375 | 173.53125 | 2 | 1.199951 | 0.699951 | 142 | 7.549805 | 151 | 15 | 3,153 | null | 0 | no(M2 and SIP pres) | 0 |
8,440 | 74.57898 | 1 | male | 0 | 8 | 567 | Lung Cancer | Cancer | 1 | null | null | 0 | 4,308 | 2,934.709 | 3,172.54883 | 6.5 | white | 13.398438 | 14 | 0.75293 | 0.495972 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | dnr before sadm | -1 | 111 | 6.799805 | 64 | 22 | 36.09375 | null | 3.199707 | 0.799927 | 1.899902 | 139 | null | 93 | 32 | 1,425 | null | null | null | 2.664063 |
8,441 | 72.97498 | 0 | female | 0 | 9 | 1,079 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 8,002 | 5,365.7031 | 4,766.54688 | 12.5 | white | 22.796875 | 37 | 0.785889 | 0.656982 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 68 | 6.299805 | 113 | 28 | 37.19531 | 244.4375 | null | null | 1 | 137 | 7.359375 | 108 | 6 | 1,384 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,442 | 77.823 | 1 | male | 0 | 8 | 776 | COPD | COPD/CHF/Cirrhosis | 1 | 11 | null | 0 | 8,005 | 5,048.3125 | 4,429.75781 | 11.5 | white | 11.398438 | 32 | 0.893921 | 0.821899 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 8 | 107 | 12.298828 | 96 | 32 | 35.69531 | null | 3.399902 | 0.799927 | 1 | 126 | null | 132 | 10 | 5,350 | 4 | 0 | no(M2 and SIP pres) | 0 |
8,443 | 77.5 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | null | 0 | 16,565 | 10,627.6406 | 25,434.0156 | 48 | white | 36.195313 | 67 | 0.329956 | 0.214996 | 4 | 0 | 0 | yes | 0.09 | 0.09 | dnr before sadm | -3 | 149 | 6.299805 | 114 | 26 | 36.69531 | 190 | 2.099609 | 1.699951 | 4.5 | 141 | 7.469727 | 211 | 92 | 438 | null | 1 | <2 mo. follow-up | 1 |
8,444 | 64.18597 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 37 | 168,012 | 105,001 | 98,044 | 42.5 | white | 26.699219 | 50 | 0.510986 | 0.394958 | 95 | 0 | 0 | no | 0.05 | 0.03 | dnr after sadm | 4 | 131 | 16.597656 | 118 | 25 | 37.69531 | 206 | 3.399902 | 0.599976 | 2.799805 | 136 | 7.399414 | 180 | 33 | 1,327 | null | 6 | <2 mo. follow-up | 6 |
8,445 | 82.55396 | 1 | female | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 8 | under $11k | 100 | 8,436 | 6,312.2773 | 6,558.98828 | 38 | white | 50.398438 | 100 | 0 | 0 | 1 | 0 | 0 | no | 0.2 | 0.02 | dnr after sadm | 4 | 67 | 14.699219 | 126 | 34 | 35.69531 | 183.3125 | 1.799805 | 0.799927 | 2.899902 | 138 | 7.369141 | 174 | 75 | 4,340 | null | null | <2 mo. follow-up | 3.834473 |
8,446 | 30.987 | 0 | female | 0 | 10 | 1,075 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 10,124 | 6,855.1562 | 6,209.31641 | 17 | white | 27.5 | 37 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | 0.85 | 0.5 | no dnr | 10 | 132 | 20.898438 | 147 | 38 | 38.59375 | 84 | 2.5 | 2.299805 | 0.799927 | 138 | 7.519531 | 238 | 19 | 3,565 | null | 0 | no(M2 and SIP pres) | 0 |
8,447 | 74.508 | 0 | male | 0 | 4 | 1,075 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 2,104 | 1,398.7158 | 1,200.2793 | 5 | white | 24.398438 | 37 | 0.691895 | 0.526978 | 1 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 1 | 97 | 15.398438 | 116 | 32 | 37.09375 | 146.03125 | 2.5 | 1 | 0.899902 | 122 | 7.239258 | 107 | 17 | 1,250 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,448 | 66.245 | 1 | male | 0 | 7 | 146 | Colon Cancer | Cancer | 1 | 10 | $11-$25k | 0 | 7,801 | 4,927.7969 | 4,473.71875 | 5.5 | white | 17.398438 | 23 | 0.80896 | 0.590942 | 1 | 0 | 0 | metastatic | 1 | 1 | dnr after sadm | 1 | 121 | 10.099609 | 80 | 28 | 36.09375 | 52.59375 | 3.399902 | 0.699951 | 0.899902 | 144 | 7.30957 | 134 | 4 | 3,630 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,449 | 66.80597 | 0 | female | 0 | 6 | 1,071 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | null | 0 | 4,827 | 3,117.4648 | 2,889.98828 | 10 | white | 15.398438 | 21 | 0.898926 | 0.830933 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 6 | 116 | 16.199219 | 139 | 10 | 35.89844 | 195.46875 | 2 | 2 | 1.199951 | 143 | 7.449219 | 296 | 47 | 3,455 | null | null | no(M2 and SIP pres) | 1.962891 |
8,450 | 61.43997 | 1 | female | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 43,480 | 29,285.5938 | 29,039 | 24.5 | white | 32.695313 | 55 | 0.60791 | 0.501953 | 5 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 8 | 63 | 21.699219 | 126 | 22 | 39.19531 | 166 | 1.399902 | 2.5 | 1 | 149 | 7.419922 | 108 | 15 | 2,063 | 0 | null | <2 mo. follow-up | 0.494751 |
8,451 | 37.54999 | 0 | male | 0 | 29 | 1,070 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | under $11k | 0 | 40,796 | 29,316.4375 | 25,175.2812 | 9.75 | white | 28.898438 | 41 | 0.777954 | 0.705933 | 11 | 1 | 0 | no | 0.8 | 0.5 | no dnr | 29 | 70 | 7.399414 | 140 | 20 | 36.79688 | null | 4.299805 | 1.099854 | 1 | 136 | null | 107 | 7 | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
8,452 | 52.88998 | 1 | male | 0 | 10 | 12 | Coma | Coma | 2 | 8 | $11-$25k | 94 | 20,327 | 13,971.5 | 13,850.3281 | 35 | white | 24.796875 | 39 | 0.334961 | 0.262939 | 1 | 1 | 0 | no | 0.1 | 0 | dnr after sadm | 4 | 75 | 4 | 74 | 20 | 37.79688 | null | 4 | 0.399963 | 0.899902 | 140 | null | 98 | 8 | null | null | 1 | <2 mo. follow-up | 1 |
8,453 | 41.862 | 1 | female | 0 | 18 | 60 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 63,260 | 44,163.5312 | 42,367.3125 | 22.333328 | white | 30.597656 | 45 | 0.660889 | 0.562988 | 5 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 18 | 143 | 8 | 100 | 20 | 36.69531 | null | 4.199219 | 0.699951 | 1.399902 | 138 | null | 101 | 18 | null | null | null | null | 2.576172 |
8,454 | 73.68097 | 1 | male | 0 | 11 | 355 | CHF | COPD/CHF/Cirrhosis | 5 | 15 | $11-$25k | 0 | 9,157 | 6,739.75 | 5,840.60938 | 9 | white | 21.296875 | 38 | 0.817993 | 0.703979 | 1 | 1 | 1 | no | null | null | no dnr | 11 | 103 | 0.189972 | 85 | 24 | 35 | 326.1875 | 2.199707 | 0.399963 | 0.5 | 129 | 7.519531 | 200 | 7 | 1,200 | 2 | 6 | SIP>=30 | 6 |
8,455 | 88.58899 | 1 | male | 0 | 5 | 666 | CHF | COPD/CHF/Cirrhosis | 1 | 3 | null | 0 | 2,930 | 2,039.8115 | 1,935.58984 | 6 | white | 20.699219 | 30 | 0.765991 | 0.628906 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 74 | 14.798828 | 52 | 30 | 37.59375 | 105 | 3.399902 | 2.899902 | 0.799927 | 131 | 7.449219 | 144 | 16 | 1,823 | null | null | no(M2 and SIP pres) | 3.377441 |
8,456 | 62.56 | 1 | male | 1 | 5 | 5 | Coma | Coma | 1 | 16 | $25-$50k | 100 | 7,629 | null | null | 21 | white | 18.398438 | 24 | 0.394958 | 0.320984 | 1 | 0 | 0 | no | 0.1 | 0 | dnr after sadm | 2 | 111 | 7 | 118 | 24 | 35.89844 | 212.5 | 3.699707 | 0.299988 | 1.599854 | 137 | 7.289062 | 122 | 48 | 2,650 | null | null | <2 mo. follow-up | 2.310547 |
8,457 | 67.82495 | 1 | female | 0 | 17 | 950 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 37 | 20,390 | 14,021.3594 | 13,929.6172 | 24.666656 | white | 31.296875 | 63 | 0.5 | 0.382996 | 1 | 1 | 0 | no | 0.85 | 0.7 | no dnr | 17 | 71 | 10.298828 | 122 | 32 | 35.79688 | 409.5 | 3.799805 | 1.699951 | 0.799927 | 115 | 7.509766 | 217 | 19 | 5,620 | null | 0 | no(M2 and SIP pres) | 0 |
8,458 | 81.82599 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 5 | null | under $11k | 0 | 9,599 | 6,960.7734 | 6,414.91797 | 34 | white | 21.5 | 48 | 0.723999 | 0.639893 | 1 | 0 | 1 | yes | 0 | 0 | dnr after sadm | 3 | 110 | 10.298828 | 80 | 22 | 36.59375 | null | 1.199951 | 1.899902 | 1.5 | 134 | null | 94 | 25 | null | null | null | <2 mo. follow-up | 4.682617 |
8,459 | 61.20697 | 1 | female | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 26 | 12,832 | 35,940.7188 | 48,020.25 | 30 | hispanic | 31.097656 | 53 | 0.532959 | 0.417969 | 5 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 79 | 5.899414 | 114 | 10 | 38 | 103.42188 | 2.199707 | 0.5 | 2.599609 | 143 | 7.449219 | 126 | 26 | 1,062 | null | null | <2 mo. follow-up | 2.608887 |
8,460 | 82.11395 | 1 | female | 0 | 16 | 719 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 26 | 20,328 | 13,797.9531 | 13,497.3359 | 20 | hispanic | 14.798828 | 13 | 0.778931 | 0.646973 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 110 | 39 | 142 | 40 | 35.89844 | 75 | 1.199951 | 0.899902 | 1.099854 | 142 | 7.509766 | 101 | 16 | 4,175 | null | 0 | no(M2 and SIP pres) | 0 |
8,461 | 70.00696 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 31,634 | 22,024.7656 | 22,053.9062 | 23 | white | 18.796875 | 20 | 0.792969 | 0.724976 | 9 | 0 | 0 | no | null | null | no dnr | 6 | 101 | 5.399414 | 104 | 20 | 36.69531 | 253.4375 | 2.699707 | 0.699951 | 1.299805 | 141 | 7.439453 | 97 | 16 | null | null | 0 | <2 mo. follow-up | 0 |
8,462 | 71.198 | 1 | female | 0 | 10 | 18 | MOSF w/Malig | ARF/MOSF | 3 | 12 | under $11k | 44 | 29,653 | 19,878.0469 | 20,414.4375 | 26 | white | 20 | 47 | 0.56189 | 0.449951 | 3 | 1 | 0 | yes | 0.95 | 0.65 | dnr after sadm | 5 | 97 | 10 | 66 | 20 | 36.19531 | 170.9375 | 3.699707 | 0.399963 | 1.099854 | 140 | 7.349609 | 118 | 10 | 4,250 | null | 1 | <2 mo. follow-up | 1 |
8,463 | 66.02899 | 1 | male | 0 | 5 | 93 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 3,923 | 2,519.0059 | 3,061.56836 | 8 | white | 13.699219 | 10 | 0.890991 | 0.817993 | 1 | 0 | 0 | yes | 0.8 | 0.6 | dnr after sadm | 1 | 133 | 4.799805 | 73 | 24 | 35.79688 | 240 | 3.599609 | 0.899902 | 0.799927 | 132 | 7.40918 | 208 | 9 | 4,354 | 4 | 5 | SIP>=30 | 5 |
8,464 | 66.086 | 1 | female | 0 | 12 | 305 | MOSF w/Malig | ARF/MOSF | 4 | null | null | 0 | 11,931 | 7,972.5547 | 9,124.96875 | 14 | white | 24.296875 | 41 | 0.689941 | 0.5979 | 1 | 0 | 0 | yes | 0.6 | 0.5 | dnr after sadm | 2 | 141 | 10.099609 | 138 | 47 | 38.69531 | 73 | 3.199707 | 0.699951 | 0.899902 | 135 | 7.369141 | 226 | 17 | 2,462 | null | null | null | 3.161133 |
8,465 | 47.76498 | 1 | female | 0 | 3 | 85 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 2,900 | 1,750.4297 | 872.52978 | null | white | 15.199219 | 11 | 0.776978 | 0.534912 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 3 | 123 | 11.199219 | 96 | 20 | 36 | 303.3125 | 3.899902 | 0.699951 | 1.299805 | 133 | 7.489258 | 130 | 11 | null | null | null | no(M2 and SIP pres) | 2.127441 |
8,466 | 67.05298 | 1 | male | 0 | 19 | 57 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 66,940 | 41,353.8438 | 41,568.0625 | 26 | white | 26.699219 | 52 | 0.518921 | 0.402954 | 34 | 0 | 0 | yes | 0.5 | 0.25 | no dnr | 19 | 129 | 14.298828 | 128 | 24 | 36.39844 | 430.6875 | 2.299805 | 1.199951 | 0.799927 | 129 | 7.519531 | 96 | 24 | 1,310 | 2 | 0 | <2 mo. follow-up | 0 |
8,467 | 56.41299 | 1 | female | 0 | 16 | 417 | Colon Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 16,094 | 10,771.8047 | 10,005.0859 | 15.666664 | white | 23.597656 | 9 | 0.730957 | 0.460999 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 16 | 68 | 14.699219 | 60 | 32 | 36.29688 | 501.625 | 3.599609 | 1.199951 | 0.599976 | 132 | 7.449219 | 125 | 20 | 1,766 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,468 | 56.67398 | 1 | female | 0 | 3 | 56 | Lung Cancer | Cancer | 1 | 14 | null | 26 | 9,091 | 6,717.8398 | 7,551.20703 | null | white | 20.097656 | 17 | 0.552979 | 0.22998 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 1 | 60 | 20.296875 | 106 | 24 | 36.39844 | 191.40625 | 2.099609 | 0.599976 | 5.5 | 147 | 7.349609 | 143 | 113 | 1,015 | null | null | <2 mo. follow-up | 2.379883 |
8,469 | 64.84094 | 0 | male | 0 | 13 | 1,054 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | null | 0 | 25,119 | 16,538.7188 | 15,737.1641 | 29.5 | white | 30.597656 | 42 | 0.658936 | 0.560913 | 3 | 1 | 0 | no | 0.85 | 0.5 | no dnr | 13 | 118 | 9.5 | 76 | 10 | 36.39844 | 178.5625 | 3.699707 | 0.599976 | 2.299805 | 142 | 7.219727 | 173 | 61 | 4,335 | null | 0 | no(M2 and SIP pres) | 0 |
8,470 | 62.20099 | 1 | male | 0 | 9 | 28 | Lung Cancer | Cancer | 3 | 8 | $25-$50k | 0 | 6,164 | 4,395.6094 | 4,622.83984 | 4 | white | 25.5 | 27 | 0.511963 | 0.189972 | 1 | 1 | 0 | metastatic | 0.25 | 0.05 | dnr after sadm | 6 | 101 | 14.099609 | 63 | 38 | 36.5 | 171.40625 | 3.199707 | 0.899902 | 1.099854 | 130 | 7.469727 | 156 | 37 | 3,945 | null | 4 | <2 mo. follow-up | 4 |
8,471 | 76.04095 | 1 | male | 1 | 3 | 3 | Coma | Coma | 1 | 8 | $11-$25k | 100 | 8,063 | 5,650.8984 | 5,565.87891 | 19 | white | 26.5 | 38 | 0.042999 | 0.021999 | 4 | 0 | 0 | no | null | null | dnr after sadm | 2 | 75 | 4 | 80 | 22 | 36.29688 | 376.625 | null | null | 1.199951 | 139 | 7.549805 | 24 | 18 | null | null | null | <2 mo. follow-up | 2.719727 |
8,472 | 75.79999 | 0 | female | 0 | 7 | 1,052 | CHF | COPD/CHF/Cirrhosis | 6 | 7 | null | 0 | 4,941 | 3,309.6856 | 2,727.34961 | 6.5 | white | 15.798828 | 13 | 0.875 | 0.791992 | 1 | 1 | 0 | no | 0.85 | 0.75 | no dnr | 7 | 74 | 23.5 | 81 | 24 | 36.09375 | 174.28125 | 3.599609 | 0.299988 | 0.799927 | 140 | 7.419922 | 125 | 9 | 1,710 | 1 | 0 | no(M2 and SIP pres) | 0 |
8,473 | 63.93997 | 0 | female | 0 | 56 | 1,052 | Coma | Coma | 1 | 14 | $11-$25k | 100 | 90,996 | 63,028.9375 | 67,949.75 | 33.25 | white | 23.398438 | 24 | 0.098999 | 0.058998 | 6 | 0 | 0 | yes | 0.8 | 0.7 | no dnr | 56 | 66 | 12 | 118 | 22 | 38.5 | 145.09375 | 2.599609 | 0.5 | 2.599609 | 149 | 7.40918 | 149 | 53 | 2,745 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,474 | 70.70197 | 1 | male | 0 | 5 | 67 | Lung Cancer | Cancer | 1 | null | null | 0 | 2,796 | 1,861.1143 | 1,850.37988 | 10 | white | 23.199219 | 15 | 0.545898 | 0.223999 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | no dnr | 5 | 58 | 24.5 | 153 | 18 | 39 | 47.19531 | 1.799805 | 1.099854 | 0.699951 | 145 | 7.349609 | 241 | 15 | 5,812 | null | null | null | 2.217773 |
8,475 | 74.43896 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | null | 26 | 45,006 | 29,696.6562 | 64,308.4062 | 36 | white | 20.199219 | 16 | 0.714966 | 0.628906 | 5 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 11 | 91 | 7.899414 | 72 | 20 | 37.59375 | null | 2.699707 | 1.799805 | 0.699951 | 132 | null | 118 | 6 | 525 | null | 0 | <2 mo. follow-up | 0 |
8,476 | 76.59698 | 1 | female | 0 | 5 | 19 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 2,698 | 1,880.1592 | 2,167.23828 | 6 | white | 19 | 19 | 0.634888 | 0.323975 | 1 | 0 | 0 | metastatic | 0.4 | 0.05 | dnr after sadm | 3 | 122 | 5.399414 | 120 | 28 | 36.59375 | 206.4375 | 3.599609 | 0.199982 | 0.799927 | 139 | 7.289062 | 129 | 10 | 1,905 | null | null | <2 mo. follow-up | 2.238281 |
8,477 | 72.44598 | 0 | male | 0 | 6 | 1,049 | CHF | COPD/CHF/Cirrhosis | 6 | 3 | under $11k | 0 | 4,549 | 3,150.8008 | 2,777.62891 | 12 | white | 19.597656 | 12 | 0.842896 | 0.74292 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 6 | 115 | 10.398438 | 75 | 10 | 36 | 203.125 | 1.899902 | 2 | 0.699951 | 127 | 7.459961 | 152 | 11 | 1,970 | null | 0 | no(M2 and SIP pres) | 0 |
8,478 | 79.409 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 8 | null | 0 | 27,343 | 18,724.5156 | 16,082.6875 | 11.666664 | white | 25.296875 | 38 | 0.72998 | 0.645996 | 1 | 1 | 0 | no | null | null | no dnr | 23 | 109 | 13.5 | 54 | 24 | 38.39844 | 382.8125 | 2.5 | 0.399963 | 0.799927 | 139 | 7.5 | 116 | 11 | 2,835 | null | 2 | <2 mo. follow-up | 2 |
8,479 | 75.46899 | 0 | female | 0 | 6 | 1,048 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 6,738 | 4,597.5352 | 4,253.64844 | 22 | white | 26.199219 | 48 | 0.731934 | 0.647949 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 103 | 11.5 | 113 | 22 | 37.19531 | 168.5625 | 2.399902 | 0.899902 | 0.799927 | 138 | 7.299805 | 183 | 28 | null | null | null | null | 1.895508 |
8,480 | 70.00098 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $11-$25k | 55 | 16,813 | 11,912.1953 | 12,922.0938 | 29 | white | 39.796875 | 70 | 0.034996 | 0.009998 | 3 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 4 | 111 | 12.298828 | 131 | 28 | 36.69531 | 275 | 2.5 | 1.599854 | 0.899902 | 138 | 7.55957 | 109 | 11 | 1,340 | null | 3 | <2 mo. follow-up | 3 |
8,481 | 64.862 | 0 | female | 0 | 5 | 1,046 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,304 | 2,222.3672 | 1,903.83984 | 6 | white | 15.798828 | 9 | 0.730957 | 0.460999 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 111 | 6.599609 | 75 | 16 | 35.79688 | null | null | null | 2.299805 | 139 | null | 301 | 40 | 1,420 | null | null | null | 1.982178 |
8,482 | 66.06396 | 0 | male | 0 | 8 | 1,045 | Colon Cancer | Cancer | 3 | 8 | under $11k | 0 | 4,612 | 3,072.0527 | 3,026.32812 | 8.5 | white | 24.398438 | 5 | 0.689941 | 0.397949 | 1 | 1 | 0 | metastatic | 0.7 | 0.4 | no dnr | 8 | 101 | 13.699219 | 61 | 24 | 36.29688 | 473.75 | null | null | 0.899902 | 130 | 7.449219 | 125 | 19 | 2,240 | null | 1 | no(M2 and SIP pres) | 1 |
8,483 | 80.70599 | 0 | male | 0 | 7 | 1,044 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | $11-$25k | 0 | 15,582 | 10,023.0312 | 10,013.4453 | 9.5 | white | 23.296875 | 28 | 0.671997 | 0.576904 | 3 | 0 | 0 | yes | 0.98 | 0.9 | no dnr | 7 | 63 | 24.796875 | 56 | 36 | 35.5 | null | 2.699707 | 1.099854 | 2 | 132 | null | 181 | 90 | 6,176 | 0 | null | null | 0.494751 |
8,484 | 20.15599 | 0 | male | 0 | 26 | 1,044 | Coma | Coma | 0 | 14 | under $11k | 26 | 66,661 | 43,215.5625 | 44,197.5 | 21 | white | 35.898438 | 54 | 0.668945 | 0.611938 | 1 | 0 | 0 | no | 0.75 | 0.9 | no dnr | 26 | 122 | 6.899414 | 62 | 12 | 37.59375 | 244 | 2.899902 | 1.099854 | 1.599854 | 145 | 7.519531 | 135 | 31 | 3,052 | null | 0 | no(M2 and SIP pres) | 0 |
8,485 | 65.68896 | 1 | male | 0 | 6 | 44 | Lung Cancer | Cancer | 2 | 14 | $11-$25k | 0 | 3,969 | 2,548.1445 | 2,030.70996 | 4 | white | 20.898438 | 12 | 0.621948 | 0.307983 | 1 | 1 | 0 | metastatic | 0.3 | 0.1 | no dnr | 6 | 81 | 4.899414 | 55 | 24 | 36.29688 | null | 3.299805 | 0.899902 | 2 | 137 | null | 88 | 31 | 1,500 | 3 | 0 | <2 mo. follow-up | 0 |
8,486 | 79.09094 | 1 | male | 0 | 9 | 926 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 6,378 | 4,197.3984 | 5,589.23828 | 6.5 | white | 16.296875 | 26 | 0.838989 | 0.735962 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 9 | 115 | 9.398438 | 91 | 20 | 36.5 | null | 3.699707 | 0.399963 | 1.5 | 133 | null | 142 | 10 | 6,275 | null | null | null | 3.007813 |
8,487 | 75.87695 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 0 | 86,926 | 56,362.8438 | 54,649.0938 | 26 | white | 24.199219 | 52 | 0.677979 | 0.583984 | 30 | 0 | 0 | no | 0.1 | 0.6 | no dnr | 20 | 33 | 13.699219 | 161 | 10 | 37.5 | 90.54688 | 1.5 | 1.399902 | 2.899902 | 138 | 7.369141 | 233 | 62 | 75 | null | 1 | <2 mo. follow-up | 1 |
8,488 | 77.29498 | 1 | male | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 89,062 | 58,730.5312 | 57,205.2188 | 30 | white | 25.398438 | 39 | 0.648926 | 0.54895 | 24 | 0 | 0 | no | 0.8 | 0.8 | dnr after sadm | 36 | 82 | 6.199219 | 96 | 24 | 36.79688 | 140.90625 | 3.899902 | 1.599854 | 1.099854 | 142 | 7.419922 | 153 | 13 | 750 | null | 1 | <2 mo. follow-up | 1 |
8,489 | 66.75397 | 1 | male | 0 | 16 | 31 | CHF | COPD/CHF/Cirrhosis | 4 | 15 | $25-$50k | 0 | 14,292 | 10,103.7656 | 8,128.36719 | 16 | white | 20 | 35 | 0.856934 | 0.763916 | 1 | 0 | 0 | no | null | null | no dnr | 16 | 115 | 8.898438 | 126 | 40 | 38.89844 | 377.5 | 2.5 | 0.699951 | 1.799805 | 144 | 7.469727 | 191 | 52 | 2,915 | 1 | 6 | <2 mo. follow-up | 6 |
8,490 | 75.79498 | 1 | male | 0 | 10 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 8 | null | 26 | 34,789 | 23,674.0156 | 23,985.4062 | 31.5 | white | 23.398438 | 50 | 0.552979 | 0.439941 | 7 | 1 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 9 | 103 | 11.298828 | 68 | 20 | 37 | 295.1875 | 3.599609 | 0.699951 | 0.899902 | 139 | 7.459961 | 181 | 14 | null | null | 1 | <2 mo. follow-up | 1 |
8,491 | 70.76495 | 1 | male | 0 | 14 | 19 | Coma | Coma | 5 | 12 | $11-$25k | 41 | 11,963 | 8,354.4531 | 8,452.02344 | 11 | white | 24.796875 | 34 | 0.426941 | 0.352966 | 1 | 1 | 1 | no | 0.3 | 0.3 | dnr before sadm | -1 | 121 | 27.398438 | 120 | 50 | 38.89844 | 235.6875 | 2 | 2.699707 | 1.099854 | 143 | 7.549805 | 115 | 16 | 2,742 | null | 4 | <2 mo. follow-up | 4 |
8,492 | 78.67798 | 0 | male | 0 | 11 | 1,038 | CHF | COPD/CHF/Cirrhosis | 5 | 8 | under $11k | 0 | 17,143 | 11,050.6875 | 11,172.0391 | 8 | white | 16.296875 | 25 | 0.860962 | 0.770996 | 1 | 0 | 0 | no | 0.95 | 0.6 | no dnr | 11 | 58 | 17.097656 | 53 | 24 | 36.39844 | null | null | null | 0.299988 | 125 | null | 88 | 8 | 1,480 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,493 | 68.97998 | 1 | male | 0 | 12 | 96 | Lung Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 6,820 | 4,525.5234 | 4,129.03906 | 3.5 | white | 13.699219 | 2 | 0.759888 | 0.505981 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 12 | 51 | 18.597656 | 112 | 16 | 38 | 84.53125 | 2 | 1.099854 | 1.099854 | 143 | 7.459961 | 123 | 18 | 1,915 | null | null | no(M2 and SIP pres) | 1.920166 |
8,494 | 40.86798 | 0 | female | 0 | 4 | 1,036 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 3,969 | 2,673.0996 | 2,444.41992 | 10 | white | 9.398438 | 21 | 0.963989 | 0.937988 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 4 | 50 | 18.699219 | 109 | 8 | 35.5 | 256.3125 | 1.699951 | 9 | 4.799805 | 141 | 7.399414 | 221 | 57 | 0 | null | null | no(M2 and SIP pres) | 1.506104 |
8,495 | 77.28998 | 1 | male | 0 | 9 | 959 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 6,355 | 4,204.3125 | 4,802.33984 | 6.5 | white | 15.199219 | 12 | 0.859985 | 0.767944 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 9 | 99 | 13.199219 | 100 | 24 | 35.79688 | 165.21875 | 3.299805 | 1.699951 | 0.699951 | 140 | 7.399414 | 128 | 10 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
8,496 | 58.34399 | 1 | male | 0 | 28 | 120 | Lung Cancer | Cancer | 2 | null | null | 26 | 48,555 | 31,352.5781 | 28,168.9531 | 25.5 | white | 24.097656 | 31 | 0.432983 | 0.125977 | 1 | 0 | 0 | metastatic | 0.4 | 0.1 | no dnr | 28 | 105 | 11.798828 | 78 | 16 | 36 | 302.8125 | 4.199219 | 0.699951 | 1.399902 | 126 | 7.399414 | 79 | 15 | 2,800 | null | null | null | 2.901367 |
8,497 | 69.50299 | 0 | male | 0 | 9 | 1,034 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | $11-$25k | 0 | 19,367 | 12,622.4766 | 12,488.125 | 14.5 | white | 33 | 40 | 0.590942 | 0.482971 | 2 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 9 | 107 | 11.599609 | 70 | 24 | 36.19531 | 284.25 | 3.699707 | 1 | 1.399902 | 145 | 7.40918 | 75 | 48 | 2,350 | 0 | 0 | no(M2 and SIP pres) | 0 |
8,498 | 77.13098 | 0 | male | 0 | 28 | 1,034 | Coma | Coma | 1 | 13 | $25-$50k | 89 | 37,480 | 25,343.3125 | 23,766.6719 | 22.75 | white | 14.5 | 21 | 0.299988 | 0.228973 | 2 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 28 | 127 | 7.899414 | 79 | 24 | 35.09375 | 266.625 | 3.599609 | 0.899902 | 2.299805 | 138 | 7.369141 | 207 | 27 | 3,055 | null | 0 | adl>=4 (>=5 if sur) | 0 |
8,499 | 80.66498 | 0 | female | 0 | 9 | 1,033 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 7,578 | 5,084.1562 | 4,947.25781 | 12 | white | 16.699219 | 15 | 0.825928 | 0.716919 | 1 | 0 | 0 | no | 0.9 | 0.5 | dnr before sadm | -1 | 112 | 3 | 104 | 16 | 36.29688 | null | 2.899902 | 4.899414 | 0.599976 | 137 | null | 90 | 9 | null | 1 | 0 | no(M2 and SIP pres) | 0 |
8,500 | 64.03595 | 1 | male | 0 | 9 | 22 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 6,096 | 4,047.0644 | 4,707.76953 | 7.5 | white | 16.398438 | 22 | 0.899902 | 0.832886 | 1 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 1 | 102 | 8.398438 | 78 | 24 | 37.89844 | null | 3 | 1.599854 | 1 | 133 | null | 101 | 9 | 3,650 | null | 0 | <2 mo. follow-up | 0 |